Home > Analytics > GENPHARMASEC

GENPHARMASEC
Intrinsic Value | Fundamental Analysis

BOM : 531592     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Apr 15,2024
Price(EOD): ₹ 2.41
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Dyes & Pigments
MCap: ₹ 133.44 Cr
Value of ₹ 1 Lac invested in GENPHARMASEC
on Apr 15,2019 (price: ₹ 9.85)

₹ 1 L

₹ 0.24 L

1W : -7% 1M : -46.3% 1Y : 7.7%
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
GENPHARMASEC -7% -46.3% 7.7%
SUDARSHAN CHEMICAL INDUSTRIES 4.5% 1.5% 53.6%
VIDHI SPECIALTY FOOD INGREDIENTS 5.5% 5.1% 41.1%
KIRI INDUSTRIES -1% -23.3% 10.2%
BODAL CHEMICALS -1.6% -5.5% 33.2%
BHAGERIA INDUSTRIES -0.7% -24.2% 17%
SHREE PUSHKAR CHEMICALS & FERTILISERS 0% -12.5% 9.6%
ASAHI SONGWON COLORS -0.6% -6.2% 83.3%
PODDAR PIGMENTS 3.6% -7.6% 38.9%

FUNDAMENTAL ANALYSIS OF GENPHARMASEC

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF GENPHARMASEC

 
Valuation Score
[As on : Apr 15,2024 ]

Ratio Standalone
P/E
P/B
P/S
116.96
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 1.14 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

8.71
P/B Calculated based on Book Value of Rs 15.33 Cr
[Latest Year - Mar2023 - Standalone Results ]

5.05
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

Financial Ratios →

Insights 💡 GENPHARMASEC is one of the potential top 14% undervalued companies ! Discover More →

FAIR VALUE OF GENPHARMASEC

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
132%
-54%
-37%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF GENPHARMASEC



GENPHARMASEC vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF GENPHARMASEC

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.2
0
0
0.07
-
-
-
-
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF GENPHARMASEC

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF GENPHARMASEC

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-18.76%
141.46%
-35.56%
785.71%
-0.33%
-92.38%
-87.71%
-73.73%
QtrlyTrend
-4
Latest Qtr: Dec2023
Quarterly Result Analysis →


GENPHARMASEC related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about GENPHARMASEC


Is GENPHARMASEC good for long term investment?

As on Apr 15,2024, the Fundamentals of GENPHARMASEC look Poor and hence it may not be good for long term investment ! See Financial Performance of GENPHARMASEC . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is GENPHARMASEC UnderValued or OverValued?

As on Apr 15,2024, GENPHARMASEC is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of GENPHARMASEC ?

As on Apr 15,2024, the Intrinsic Value of GENPHARMASEC is Rs. 3.84 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1.04
Fair Value [Median EV / Sales Model] : Rs. 5.21
Fair Value [Median Price / Sales Model] : Rs. 3.84
Estimated Median Fair Value of GENPHARMASEC : Rs. 3.84

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is GENPHARMASEC trading at a Premium or Discount?

As on Apr 15,2024, GENPHARMASEC is trading at a Discount of -37% based on the estimates of Median Intrinsic Value!